Gabrielová Eva Ph.D.

Gabrielová Eva Ph.D.'s picture
Academic Title: Ing.
Phone: 585 63 2324
Curriculum Vitae: download

Publications (Impact Factor Journals):

  • [5]
    GABRIELOVÁ, E., L. BARTOSIKOVA, J. NECAS a M. MODRIANSKÝ. Cardioprotective effect of 2,3-dehydrosilybin preconditioning in isolated rat heart. Fitoterapia. 2018, 132, 12-21. ISSN 0367-326X. IF: 2.642. PMID: 30385403
  • [4]
    GABRIELOVÁ, E., A.V. ZHOLOBENKO, L. BARTOSIKOVA, J. NECAS a M. MODRIANSKÝ. Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart. PLOS One. 2015, 10(9), e0139208. ISSN 1932-6203. IF: 3.057. PMID: 26418338
  • [3]
    SKOPALIK, J., K. POLAKOVA, M. HAVRDOVA, I. JUSTAN, M. MAGRO, D. MILDE, L. KNOPFOVA, J. SMARDA, H. POLAKOVA, E. GABRIELOVÁ, F. VIANELLO, J. MICHÁLEK a R. ZBOŘIL. Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro study. International Journal of Nanomedicine. 2014, 9, 5355-5372. ISSN 1178-2013. IF: 4.383. PMID: 25484583
  • [2]
    GABRIELOVÁ, E., V. KREN, M. JABUREK a M. MODRIANSKÝ. Silymarin component 2,3-dehydrosilybin attenuates cardiomyocyte damage following hypoxia/reoxygenation by limiting oxidative stress. Physiological Research . 2015, 64(1), 79-91. ISSN 0862-8408. IF: 1.643. PMID: 25194130
  • [1]
    KREN, V., P. MARHOL, K. PURCHARTOVA, E. GABRIELOVÁ a M. MODRIANSKÝ. Biotransformation of Silybin and its Congeners. Current Drug Metabolism. 2013, 14(10), 1009-21. ISSN 1389-2002. IF: 3.487. PMID: 24261705